Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 3Phase 4 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Pain 2Neoplasm Metastasis 2Bone Neoplasms 2Lung Neoplasms 1

Interventions

Zoledronic Acid 5Bevacizumab 3exemestane 2Therapeutics 2Standard of Care 2Pamidronate 2Oxaliplatin 2Misoprostol 2Magnetic Resonance Spectroscopy 2Letrozole 2Ibandronic Acid 2Fulvestrant 2Fluorouracil 2Cetuximab 2Capecitabine 2vandetanib 1palbociclib 1liposomal doxorubicin 1huaier 1eribulin 1enzalutamide 1darolutamide 1cabozantinib 1aldesleukin 1abemaciclib 1Vindesine 1Trastuzumab 1Sugars 1Stents 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm Metastasis × Ibandronic Acid × Clear all
NCT02564107 2016-11-02

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Hoffmann-La Roche

Phase 4 Completed
48 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT02553707 2015-09-17

A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

Hoffmann-La Roche

Phase 4 Completed
182 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡